AQEMIA Company
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AI and atomic scale physics, to design novel drugs tailored for specific therapeutic targets.
Total Funding:
109502027
Founded Date:
2019-06-13
Industry:
Quantum Chemistry
Employee Number:
101-250
Last Funding Date:
2025-04-01
Funding Status:
private
Headquarters:
Paris,Ile-de-France,France,Europe
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
109502027
Last Funding Total Usd:
7400000
Last Funding Total Currency:
USD
Last Funding Total Value:
7400000
Founders:
Emmanuelle Rolland-Martiano,Maximilien Levesque